Verve Therapeutics is utilizing two of the biggest scientific breakthroughs of the twenty-first century – DNA sequencing and genome editing – to design a one-time treatment for lowering cholesterol.
Read Time:
This article is based on research findings that are yet to be peer-reviewed. Results are therefore regarded as preliminary and should be interpreted as such. Find out about the role of the peer review process in research here. For further information, please contact the cited source.
A variant of the SARS-CoV-2 virus known as B.1.1.7 â or VOC202012/01 â has been identified in the UK and classified as a variant of concern by Public Health England (PHE).
The variant appears to be linked to the rising number of COVID-19 cases in the UK that ultimately led Prime Minister Boris Johnson to declare a nationwide lockdown on January 5.